- Home
- CZNC vs OABI Comparison
CZNC vs OABI Comparison
Compare CZNC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZNC
- OABI
- Stock Information
- Founded
- CZNC 1864
- OABI 2012
- Country
- CZNC United States
- OABI United States
- Employees
- CZNC N/A
- OABI N/A
- Industry
- CZNC Major Banks
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- CZNC Finance
- OABI Health Care
- Exchange
- CZNC Nasdaq
- OABI Nasdaq
- Market Cap
- CZNC 330.3M
- OABI 307.4M
- IPO Year
- CZNC N/A
- OABI N/A
- Fundamental
- Price
- CZNC $19.68
- OABI $2.40
- Analyst Decision
- CZNC
- OABI Strong Buy
- Analyst Count
- CZNC 0
- OABI 3
- Target Price
- CZNC N/A
- OABI $7.00
- AVG Volume (30 Days)
- CZNC 24.2K
- OABI 785.5K
- Earning Date
- CZNC 05-06-2025
- OABI 03-18-2025
- Dividend Yield
- CZNC 5.55%
- OABI N/A
- EPS Growth
- CZNC 7.45
- OABI N/A
- EPS
- CZNC 1.69
- OABI N/A
- Revenue
- CZNC $106,129,000.00
- OABI $26,391,000.00
- Revenue This Year
- CZNC $9.38
- OABI $77.72
- Revenue Next Year
- CZNC $3.77
- OABI $30.95
- P/E Ratio
- CZNC $11.96
- OABI N/A
- Revenue Growth
- CZNC 1.43
- OABI N/A
- 52 Week Low
- CZNC $16.50
- OABI $2.23
- 52 Week High
- CZNC $22.68
- OABI $5.54
- Technical
- Relative Strength Index (RSI)
- CZNC 45.16
- OABI 30.90
- Support Level
- CZNC $20.24
- OABI $2.38
- Resistance Level
- CZNC $20.71
- OABI $2.57
- Average True Range (ATR)
- CZNC 0.44
- OABI 0.19
- MACD
- CZNC 0.01
- OABI -0.06
- Stochastic Oscillator
- CZNC 42.14
- OABI 17.04
About CZNC Citizens & Northern Corp
Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.